Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
J&J (JNJ) Gets FDA Nod for HIV Jab, Cabenuva, in Adolescents
04:28pm, Wednesday, 30'th Mar 2022 Zacks Investment Research
The FDA approves Johnson & Johnson's (JNJ) Cabenuva for treating HIV-1 in virologically suppressed adolescents aged 12 years and above.
3 Charts You Have to See Before Buying Moderna
02:53pm, Wednesday, 30'th Mar 2022 The Motley Fool
Could the gravy train be coming to an end?
5 Charts That Show Why Bristol-Myers Squibb Is a No-Brainer Buy
02:15pm, Wednesday, 30'th Mar 2022 The Motley Fool
The company gives investors plenty of reasons to buy and hold the stock for years.
Is SPDR MSCI USA StrategicFactors ETF (QUS) a Strong ETF Right Now?
10:20am, Wednesday, 30'th Mar 2022 Zacks Investment Research
Smart Beta ETF report for QUS
Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know
09:45pm, Monday, 28'th Mar 2022 Zacks Investment Research
Johnson & Johnson (JNJ) closed the most recent trading day at $177.83, moving +0.51% from the previous trading session.
Is Vanguard Dividend Appreciation ETF (VIG) a Strong ETF Right Now?
10:20am, Monday, 28'th Mar 2022 Zacks Investment Research
Smart Beta ETF report for VIG
Are These 2 Rivals Beating Pfizer and Moderna?
10:00am, Monday, 28'th Mar 2022 The Motley Fool
They're winning when it comes to orders.
4 Dividends That Thrive In A Market Storm And Pay 7.6%+
09:04am, Monday, 28'th Mar 2022 Investing.com
Which Company Has the Biggest COVID Program? The Answer Isn't Moderna.
12:00pm, Sunday, 27'th Mar 2022 The Motley Fool
Another player has stuffed its pipeline with many coronavirus candidates.
Is Vaxart the Next Moderna?
03:15pm, Saturday, 26'th Mar 2022 The Motley Fool
The similarities are striking.
Options Income Series: Earn High Income Safely And Consistently - March 2022
01:30pm, Saturday, 26'th Mar 2022 Seeking Alpha
Selling cash-covered puts and covered calls is a safer choice and earns a high income. How do you formulate an options income strategy? Click here to find out.
Is Johnson & Johnson Setting a Dangerous Precedent for the Healthcare Industry?
11:00am, Saturday, 26'th Mar 2022 The Motley Fool
The company will likely save billions of dollars due to a controversial Texas bankruptcy law.
Airport-based study found first U.S. case of BA.2 subvariant of omicron in December
05:43pm, Friday, 25'th Mar 2022 MarketWatch
An airport-based COVID-19 surveillance program detected the first known U.S. case of the highly transmissible omicron BA.2 subvariant in December, according to a new study that was funded by the Cente
3 Top Healthcare Stocks to Buy for the Long Haul
02:00pm, Friday, 25'th Mar 2022 The Motley Fool
A couple of these stocks have been down big this year and could be overdue for a rally.
Halozyme (HALO) Inks Collaboration Deal With Chugai Pharma
01:47pm, Friday, 25'th Mar 2022 Zacks Investment Research
Halozyme (HALO) and Japan-based Chugai Pharma sign a collaboration agreement, which gives the latter an exclusive right to Halozyme's ENHANZE technology to develop a therapy for an undisclosed target.
